Learn More
not available at time of publication. L2 Biomarkers for the diagnosis and prediction of therapeutic response in clinical breast cancer J Bartlett Breast Cancer Research 2010, 12(Suppl 1):L2 (doi: 10.1186/bcr2490) Abstract not available at time of publication.not available at time of publication. L3 Recent advances in treatment of metastatic breast cancer R(More)
People with Cystic Fibrosis have a high risk of MRSA infection. Prevalence has increased from 7% of patients in 2001 to 17.2% of patients in 2005 in the USA (1). It is unclear whether MRSA respiratory infection influences lung function, which antibiotics (if any) should be used to treat MRSA infection and for how long. This study investigates the prevalence(More)
e13541 Background: Malignant mesothelioma is an aggressive tumor refractory to current therapies and this may be due to intrinsic apoptosis resistance. Vinorelbine has been shown to exhibit useful clinical activity in phase II trials and showed a trend to improved survival as front-line monotherapy in the MS01 phase III study. BRCA1 has been reported to(More)
e13519 Background: Evasion of apoptosis contributes to both tumorigenesis and drug resistance. The proapoptotic BCL-2 family proteins BAX and BAK are critical regulators of mitochondrial apoptosis. In contrast, prosurvival BCL-2 family proteins eg. MCL-1 and BCLX are among the most frequently amplified in human cancers, consistent with negative regulation(More)
not available at time of publication. L2 Biomarkers for the diagnosis and prediction of therapeutic response in clinical breast cancer J Bartlett Breast Cancer Research 2010, 12(Suppl 1):L2 (doi: 10.1186/bcr2490) Abstract not available at time of publication.not available at time of publication. L3 Recent advances in treatment of metastatic breast cancer R(More)
  • 1